The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.
The Scientist
Most Recent
Biotech stocks fell in response to the news.
The gene-editing tool was effective in disabling a defective gene responsible for some forms of amyotrophic lateral sclerosis.
Infected with Wolbachia, the insects are expected to reduce the spread of dengue and Zika. But scientists say the approach may have limitations.
A team of scientists confirm Wolbachia can prevent mosquitoes from transmitting the virus, while another group finds a reliable way to detect the bacteria.
Officials’ increased emphasis on mosquito control could benefit public health efforts beyond the ongoing Zika outbreak.
A Brazilian town will ramp up the release of insects engineered to shrink mosquito populations.
Researchers deploy ancestors of today’s adeno-associated viruses to deliver gene therapies without immune system interference.
In a mouse model of a rare disease, scientists have figured out how to reduce the elevated cancer risk tied to a gene therapy treatment.
Directed evolution of a gene therapy virus vector improves its penetration into the retina.
Popular Now
-
The Nutshell Salk Institute Suspends Cancer Scientist Inder Verma -
The Nutshell Long-Term Study Reveals Flip in Plant Responses to Carbon Dioxide The 20-year project calls into question the conventional wisdom about the role plants will play in mitigating future climate change.
-
The Nutshell Jim Bridenstine Confirmed to Lead NASA The US Senate narrowly approved the politician, who does not have a science background.
-
Daily News RNA Injection Restores Hearing in Guinea Pigs Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
Current Issue
© 1986-2018 The Scientist
